Immunodeficiency


Immunodeficiency or immunocompromise is a state in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. Most cases of immunodeficiency are acquired due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition. In the clinical setting, the immunosuppression by some drugs, such as steroids, can be either an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency. A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised person may be particularly vulnerable to opportunistic infections, in addition to normal infections that could affect everyone. Immunodeficiency also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Types

By affected component

In reality, immunodeficiency often affects multiple components, with notable examples including severe combined immunodeficiency and acquired immune deficiency syndrome.
Affected componentsMain causesMain pathogens of resultant infections
Humoral immune deficiency
B cell deficiency
B cells, plasma cells or antibodies
  • Primary humoral
  • Multiple myeloma
  • Chronic lymphoid leukemia
  • AIDS
  • Streptococcus pneumoniae
  • Hemophilus influenzae
  • Pneumocystis jirovecii
  • Giardia intestinalis
  • Cryptosporidium parvum
  • T cell deficiencyT cells
  • Marrow and other transplantation
  • AIDS
  • Cancer chemotherapy
  • Lymphoma
  • Glucocorticoid therapy
  • Intracellular pathogens, including Herpes simplex virus, Mycobacterium, Listeria, and intracellular fungal infections.
    NeutropeniaNeutrophil granulocytes
  • Chemotherapy
  • Bone marrow transplantation
  • Dysfunction, such as chronic granulomatous disease
  • Enterobacteriaceae
  • Oral Streptococci
  • Pseudomonas aeruginosa
  • Enterococcus species
  • Candida species
  • Aspergillus species
  • AspleniaSpleen
  • Splenectomy
  • Trauma
  • Sickle-cell anemia
  • Polysaccharide encapsulated bacteria, particularly:
  • *Streptococcus pneumoniae
  • *Haemophilus influenzae
  • *Neisseria meningitidis
  • Plasmodium species
  • Babesia species
  • Complement deficiencyComplement system
  • Congenital deficiencies
  • Neisseria species
  • Streptococcus pneumoniae
  • Primary or secondary

    Distinction between primary versus secondary immunodeficiencies are based on, respectively, whether the cause originates in the immune system itself or is, in turn, due to insufficiency of a supporting component of it or an external decreasing factor of it.

    Primary immunodeficiency

    A number of rare diseases feature a heightened susceptibility to infections from childhood onward. Primary Immunodeficiency is also known as congenital immunodeficiencies. Many of these disorders are hereditary and are autosomal recessive or X-linked. There are over 95 recognised primary immunodeficiency syndromes; they are generally grouped by the part of the immune system that is malfunctioning, such as lymphocytes or granulocytes.
    The treatment of primary immunodeficiencies depends on the nature of the defect, and may involve antibody infusions, long-term antibiotics and stem cell transplantation. The characteristics of lacking and/or impaired antibody functions can be related to illnesses such as X-Linked Agammaglobulinemia and Common Variable Immune Deficiency

    Secondary immunodeficiencies

    Secondary immunodeficiencies, also known as acquired immunodeficiencies, can result from various immunosuppressive agents, for example, malnutrition, aging, particular medications and environmental toxins like mercury and other heavy metals, pesticides and petrochemicals like styrene, dichlorobenzene, xylene, and ethylphenol. For medications, the term immunosuppression generally refers to both beneficial and potential adverse effects of decreasing the function of the immune system, while the term immunodeficiency generally refers solely to the adverse effect of increased risk for infection.
    Many specific diseases directly or indirectly cause immunosuppression. This includes many types of cancer, particularly those of the bone marrow and blood cells, and certain chronic infections. Immunodeficiency is also the hallmark of acquired immunodeficiency syndrome, caused by the human immunodeficiency virus. HIV directly infects a small number of T helper cells, and also impairs other immune system responses indirectly.
    Various hormonal and metabolic disorders can also result in immune deficiency including anemia, hypothyroidism and hyperglycemia.
    Smoking, alcoholism and drug abuse also depress immune response.

    Immunodeficiency and autoimmunity

    There are a large number of immunodeficiency syndromes that present clinical and laboratory characteristics of autoimmunity. The decreased ability of the immune system to clear infections in these patients may be responsible for causing autoimmunity through perpetual immune system activation.
    One example is common variable immunodeficiency where multiple autoimmune diseases are seen, e.g., inflammatory bowel disease, autoimmune thrombocytopenia, and autoimmune thyroid disease.
    Familial hemophagocytic lymphohistiocytosis, an autosomal recessive primary immunodeficiency, is another example. Low blood levels of red blood cells, white blood cells, and platelets, rashes, lymph node enlargement, and enlargement of the liver and spleen are commonly seen in these patients. Presence of multiple uncleared viral infections due to lack of perforin are thought to be responsible.
    In addition to chronic and/or recurrent infections many autoimmune diseases including arthritis, autoimmune hemolytic anemia, scleroderma and type 1 diabetes are also seen in X-linked agammaglobulinemia.
    Recurrent bacterial and fungal infections and chronic inflammation of the gut and lungs are seen in chronic granulomatous disease as well. CGD is caused by a decreased production of nicotinamide adenine dinucleotide phosphate oxidase by neutrophils.
    Hypomorphic RAG mutations are seen in patients with midline granulomatous disease; an autoimmune disorder that is commonly seen in patients with granulomatosis with polyangiitis and NK/T cell lymphomas.
    Wiskott–Aldrich syndrome patients also present with eczema, autoimmune manifestations, recurrent bacterial infections and lymphoma.
    In autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy also autoimmunity and infections coexist: organ-specific autoimmune manifestations and chronic mucocutaneous candidiasis.
    Finally, IgA deficiency is also sometimes associated with the development of autoimmune and atopic phenomena.

    Causes

    The cause of immunodeficiency varies depending on the nature of the disorder. The cause can be either genetic or acquired by malnutrition and poor sanitary conditions. Only for some genetic causes, the exact genes are known.

    Treatment

    Available treatment falls into two modalities: treating infections and boosting the immune system.
    Prevention of Pneumocystis pneumonia using trimethoprim/sulfamethoxazole is useful in those who are immunocompromised. In the early 1950s Immunoglobulin was used by doctors to treat patients with primary immunodeficiency through intramuscular injection. Ig replacement therapy are infusions that can be either subcutaneous or intravenously administrated, resulting in higher Ig levels for about three to four weeks, although this varies with each patient.

    Prognosis

    Prognosis depends greatly on the nature and severity of the condition. Some deficiencies cause early mortality, others with or even without treatment are lifelong conditions that cause little mortality or morbidity. Newer stem cell transplant technologies may lead to gene based treatments of
    debilitating and fatal genetic immune deficiencies. Prognosis of acquired immune deficiencies depends on avoiding or treating the causative agent or
    condition.